Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Prescribing patterns from medical chart abstraction of patients administered lipegfilgrastim: a pilot study in Europe.

Kaplan S, Lang N, Gasparic M, Rainville C, Haralabopoulos G, Borroni E.

J Drug Assess. 2019 May 3;8(1):70-76. doi: 10.1080/21556660.2019.1604376. eCollection 2019.

2.

Male age: negative impact on sperm DNA fragmentation.

Albani E, Castellano S, Gurrieri B, Arruzzolo L, Negri L, Borroni EM, Levi-Setti PE.

Aging (Albany NY). 2019 May 14;11(9):2749-2761. doi: 10.18632/aging.101946.

3.

Corrigendum to "Chemokines sound the alarmin: The role of atypical chemokine receptors in inflammation and cancer" [Semin. Immunol. 38 (2018) 63-71].

Borroni EM, Savino B, Bonecchi R, Locati M.

Semin Immunol. 2019 Apr 22. pii: S1044-5323(19)30009-0. doi: 10.1016/j.smim.2019.02.002. [Epub ahead of print] No abstract available.

PMID:
31023513
4.

FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice.

Merlin S, Famà R, Borroni E, Zanolini D, Bruscaggin V, Zucchelli S, Follenzi A.

Blood Adv. 2019 Mar 12;3(5):825-838. doi: 10.1182/bloodadvances.2018027979.

5.

Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.

Vacchini A, Mortier A, Proost P, Locati M, Metzemaekers M, Borroni EM.

Int J Mol Sci. 2018 Nov 27;19(12). pii: E3768. doi: 10.3390/ijms19123768.

6.

Synthesis and antimycobacterial activity of (+)-usnic acid conjugates.

Cirillo D, Borroni E, Festoso I, Monti D, Romeo S, Mazier D, Verotta L.

Arch Pharm (Weinheim). 2018 Dec;351(12):e1800177. doi: 10.1002/ardp.201800177. Epub 2018 Nov 8.

PMID:
30407647
7.

Automated detection of bacterial growth on 96-well plates for high-throughput drug susceptibility testing of Mycobacterium tuberculosis.

Fowler PW, Gibertoni Cruz AL, Hoosdally SJ, Jarrett L, Borroni E, Chiacchiaretta M, Rathod P, Lehmann S, Molodtsov N, Walker TM, Robinson E, Hoffmann H, Peto TEA, Cirillo DM, Smith GE, Crook DW.

Microbiology. 2018 Dec;164(12):1522-1530. doi: 10.1099/mic.0.000733. Epub 2018 Oct 23.

PMID:
30351270
8.

Chemokines sound the alarmin: The role of atypical chemokine in inflammation and cancer.

Borroni EM, Savino B, Bonecchi R, Locati M.

Semin Immunol. 2018 Aug;38:63-71. doi: 10.1016/j.smim.2018.10.005. Epub 2018 Oct 15. Review. Erratum in: Semin Immunol. 2019 Apr 22;:.

PMID:
30337241
9.

Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex.

Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E.

Int J Syst Evol Microbiol. 2018 Nov;68(11):3557-3562. doi: 10.1099/ijsem.0.003031. Epub 2018 Sep 11.

PMID:
30204586
10.

Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.

Pinard E, Borroni E, Koerner A, Umbricht D, Alberati D.

Chimia (Aarau). 2018 Aug 22;72(7):477-484. doi: 10.2533/chimia.2018.477.

PMID:
30158010
11.

A case report of mucocutaneous tuberculosis after orthotopic liver transplantation: a challenging diagnosis.

Riccardi N, Cenderello G, Borroni E, Rutigliani M, Cirillo DM.

BMC Infect Dis. 2018 Aug 29;18(1):431. doi: 10.1186/s12879-018-3347-7.

12.

Evaluation of 18F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain.

Kuwabara H, Comley RA, Borroni E, Honer M, Kitmiller K, Roberts J, Gapasin L, Mathur A, Klein G, Wong DF.

J Nucl Med. 2018 Dec;59(12):1877-1884. doi: 10.2967/jnumed.118.214437. Epub 2018 Aug 10.

13.

PPARs are mediators of anti-cancer properties of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid.

Ricci M, Miola M, Multari C, Borroni E, Canuto RA, Congiusta N, Vernè E, Follenzi A, Muzio G.

Chem Biol Interact. 2018 Aug 25;292:9-14. doi: 10.1016/j.cbi.2018.07.003. Epub 2018 Jul 3.

PMID:
29986832
14.

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.

Rancoita PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, Hoosdally SJ, Walker TM, Grazian C, Davies TJ, Peto TEA, Crook DW, Fowler PW, Cirillo DM; CRyPTIC Consortiumfor the CRyPTIC Consortiumfor the CRyPTIC Consortium.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00344-18. doi: 10.1128/AAC.00344-18. Print 2018 Sep.

15.

Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects.

Wong DF, Comley RA, Kuwabara H, Rosenberg PB, Resnick SM, Ostrowitzki S, Vozzi C, Boess F, Oh E, Lyketsos CG, Honer M, Gobbi L, Klein G, George N, Gapasin L, Kitzmiller K, Roberts J, Sevigny J, Nandi A, Brasic J, Mishra C, Thambisetty M, Mogekar A, Mathur A, Albert M, Dannals RF, Borroni E.

J Nucl Med. 2018 Dec;59(12):1869-1876. doi: 10.2967/jnumed.118.209916. Epub 2018 May 4. Erratum in: J Nucl Med. 2019 Jan;60(1):141.

16.

Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.

Mustazzolu A, Borroni E, Cirillo DM, Giannoni F, Iacobino A; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA), Fattorini L.

Eur Respir J. 2018 Jul 19;52(1). pii: 1800070. doi: 10.1183/13993003.00070-2018. Print 2018 Jul. No abstract available.

PMID:
29724919
17.

Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis.

Miotto P, Cabibbe AM, Borroni E, Degano M, Cirillo DM.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01599-17. doi: 10.1128/JCM.01599-17. Print 2018 May.

18.

Corrigendum to "Innovative superparamagnetic iron-oxide nanoparticles coated with silica and conjugated with linoleic acid: Effect on tumor cell growth and viability" [Mater. Sci. Eng. C 76 (2017) 439-447].

Muzio G, Miola M, Ferraris S, Maggiora M, Bertone E, Puccinelli MP, Ricci M, Borroni E, Canuto RA, Verné E, Follenzi A.

Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:198. doi: 10.1016/j.msec.2017.12.027. Epub 2018 Feb 3. No abstract available.

PMID:
29525093
19.

Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Grizzi F, Basso G, Borroni EM, Cavalleri T, Bianchi P, Stifter S, Chiriva-Internati M, Malesci A, Laghi L.

Inflamm Res. 2018 May;67(5):375-389. doi: 10.1007/s00011-017-1128-1. Epub 2018 Jan 10. Review.

PMID:
29322204
20.

Preclinical Evaluation of 18F-RO6958948, 11C-RO6931643, and 11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease.

Honer M, Gobbi L, Knust H, Kuwabara H, Muri D, Koerner M, Valentine H, Dannals RF, Wong DF, Borroni E.

J Nucl Med. 2018 Apr;59(4):675-681. doi: 10.2967/jnumed.117.196741. Epub 2017 Sep 28.

21.

Mycobacterium aquaticum sp. nov., a rapidly growing species isolated from haemodialysis water.

Hashemi Shahraki A, Trovato A, Droz S, Haidarieh P, Borroni E, Mirsaeidi M, Mannino R, Hashemzadeh M, Mariottini A, Cirillo DM, Tortoli E.

Int J Syst Evol Microbiol. 2017 Sep;67(9):3279-3282. doi: 10.1099/ijsem.0.002103. Epub 2017 Aug 22.

PMID:
28829035
22.

Tumor targeting by lentiviral vectors combined with magnetic nanoparticles in mice.

Borroni E, Miola M, Ferraris S, Ricci G, Žužek Rožman K, Kostevšek N, Catizone A, Rimondini L, Prat M, Verné E, Follenzi A.

Acta Biomater. 2017 Sep 1;59:303-316. doi: 10.1016/j.actbio.2017.07.007. Epub 2017 Jul 5.

PMID:
28688987
23.

Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography.

Gobbi LC, Knust H, Körner M, Honer M, Czech C, Belli S, Muri D, Edelmann MR, Hartung T, Erbsmehl I, Grall-Ulsemer S, Koblet A, Rueher M, Steiner S, Ravert HT, Mathews WB, Holt DP, Kuwabara H, Valentine H, Dannals RF, Wong DF, Borroni E.

J Med Chem. 2017 Sep 14;60(17):7350-7370. doi: 10.1021/acs.jmedchem.7b00632. Epub 2017 Jul 12.

PMID:
28654263
24.

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Disease.

Borroni E, Bohrmann B, Grueninger F, Prinssen E, Nave S, Loetscher H, Chinta SJ, Rajagopalan S, Rane A, Siddiqui A, Ellenbroek B, Messer J, Pähler A, Andersen JK, Wyler R, Cesura AM.

J Pharmacol Exp Ther. 2017 Sep;362(3):413-423. doi: 10.1124/jpet.117.241653. Epub 2017 Jun 22.

PMID:
28642233
25.

Mycobacterium persicum sp. nov., a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri.

Shahraki AH, Trovato A, Mirsaeidi M, Borroni E, Heidarieh P, Hashemzadeh M, Shahbazi N, Cirillo DM, Tortoli E.

Int J Syst Evol Microbiol. 2017 Jun;67(6):1766-1770. doi: 10.1099/ijsem.0.001862. Epub 2017 Jun 20.

PMID:
28629501
26.

A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.

Merlin S, Cannizzo ES, Borroni E, Bruscaggin V, Schinco P, Tulalamba W, Chuah MK, Arruda VR, VandenDriessche T, Prat M, Valente G, Follenzi A.

Mol Ther. 2017 Aug 2;25(8):1815-1830. doi: 10.1016/j.ymthe.2017.04.029. Epub 2017 May 26.

27.

Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).

Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P.

J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.

28.

Innovative superparamagnetic iron-oxide nanoparticles coated with silica and conjugated with linoleic acid: Effect on tumor cell growth and viability.

Muzio G, Miola M, Ferraris S, Maggiora M, Bertone E, Puccinelli MP, Ricci M, Borroni E, Canuto RA, Verné E, Follenzi A.

Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:439-447. doi: 10.1016/j.msec.2017.03.063. Epub 2017 Mar 10. Erratum in: Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:198.

29.

Proteomic profile of maternal-aged blastocoel fluid suggests a novel role for ubiquitin system in blastocyst quality.

Tedeschi G, Albani E, Borroni EM, Parini V, Brucculeri AM, Maffioli E, Negri A, Nonnis S, Maccarrone M, Levi-Setti PE.

J Assist Reprod Genet. 2017 Feb;34(2):225-238. doi: 10.1007/s10815-016-0842-x. Epub 2016 Dec 6.

30.

Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects.

Barret O, Alagille D, Sanabria S, Comley RA, Weimer RM, Borroni E, Mintun M, Seneca N, Papin C, Morley T, Marek K, Seibyl JP, Tamagnan GD, Jennings D.

J Nucl Med. 2017 Jul;58(7):1124-1131. doi: 10.2967/jnumed.116.182881. Epub 2016 Dec 1.

31.

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, Codecasa LR, Cugnata F, Di Serio C, Ferrarese M, Goletti D, Lipman M, Rancoita PM, Russo G, Tadolini M, Vanino E, Cirillo DM.

Eur Respir J. 2016 Nov;48(5):1411-1419. doi: 10.1183/13993003.00510-2016. Epub 2016 Jul 7.

32.

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy.

Smith R, Schain M, Nilsson C, Strandberg O, Olsson T, Hägerström D, Jögi J, Borroni E, Schöll M, Honer M, Hansson O.

Mov Disord. 2017 Jan;32(1):108-114. doi: 10.1002/mds.26813. Epub 2016 Oct 6.

33.

Lentiviral vector interactions with the host cell.

Borsotti C, Borroni E, Follenzi A.

Curr Opin Virol. 2016 Dec;21:102-108. doi: 10.1016/j.coviro.2016.08.016. Epub 2016 Sep 13. Review.

PMID:
27637073
34.

Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system-authors' response.

Hoffmann H, Borroni E, Schena E, Nedialkova L, Hofmann-Thiel S, Cirillo D.

J Antimicrob Chemother. 2016 Dec;71(12):3625. Epub 2016 Sep 12. No abstract available.

PMID:
27621178
35.

The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis.

Devonshire AS, O'Sullivan DM, Honeyborne I, Jones G, Karczmarczyk M, Pavšič J, Gutteridge A, Milavec M, Mendoza P, Schimmel H, Van Heuverswyn F, Gorton R, Cirillo DM, Borroni E, Harris K, Barnard M, Heydenrych A, Ndusilo N, Wallis CL, Pillay K, Barry T, Reddington K, Richter E, Mozioğlu E, Akyürek S, Yalçınkaya B, Akgoz M, Žel J, Foy CA, McHugh TD, Huggett JF.

BMC Infect Dis. 2016 Aug 3;16:366. doi: 10.1186/s12879-016-1696-7.

36.

Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.

Schena E, Nedialkova L, Borroni E, Battaglia S, Cabibbe AM, Niemann S, Utpatel C, Merker M, Trovato A, Hofmann-Thiel S, Hoffmann H, Cirillo DM.

J Antimicrob Chemother. 2016 Jun;71(6):1532-9. doi: 10.1093/jac/dkw044. Epub 2016 Apr 13.

PMID:
27076101
37.

MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Using QIAxcel Technology: A Multicentre Evaluation Study.

Nikolayevskyy V, Trovato A, Broda A, Borroni E, Cirillo D, Drobniewski F.

PLoS One. 2016 Mar 3;11(3):e0149435. doi: 10.1371/journal.pone.0149435. eCollection 2016.

38.

Analysis of G Protein and β-Arrestin Activation in Chemokine Receptors Signaling.

Vacchini A, Busnelli M, Chini B, Locati M, Borroni EM.

Methods Enzymol. 2016;570:421-40. doi: 10.1016/bs.mie.2015.09.016. Epub 2015 Nov 14.

PMID:
26921957
39.

SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells.

Pinton G, Zonca S, Manente AG, Cavaletto M, Borroni E, Daga A, Jithesh PV, Fennell D, Nilsson S, Moro L.

Oncotarget. 2016 Mar 22;7(12):14366-79. doi: 10.18632/oncotarget.7321.

40.

First independent evaluation of QuantiFERON-TB Plus performance.

Barcellini L, Borroni E, Brown J, Brunetti E, Codecasa L, Cugnata F, Dal Monte P, Di Serio C, Goletti D, Lombardi G, Lipman M, Rancoita PM, Tadolini M, Cirillo DM.

Eur Respir J. 2016 May;47(5):1587-90. doi: 10.1183/13993003.02033-2015. Epub 2016 Feb 11. No abstract available.

41.

Tuberculosis in migrants from 106 countries to Italy, 2008-2014.

Fattorini L, Mustazzolu A, Borroni E, Piccaro G, Giannoni F, Cirillo DM; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group.

Eur Respir J. 2016 Apr;47(4):1273-6. doi: 10.1183/13993003.01844-2015. Epub 2016 Feb 4. No abstract available.

42.

Overview and potential unifying themes of the atypical chemokine receptor family.

Vacchini A, Locati M, Borroni EM.

J Leukoc Biol. 2016 Jun;99(6):883-92. doi: 10.1189/jlb.2MR1015-477R. Epub 2016 Jan 6. Review.

PMID:
26740381
43.

Implementation of a Consensus Set of Hypervariable Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Loci in Mycobacterium tuberculosis Molecular Epidemiology.

Trovato A, Tafaj S, Battaglia S, Alagna R, Bardhi D, Kapisyzi P, Bala S, Haldeda M, Borroni E, Hafizi H, Cirillo DM.

J Clin Microbiol. 2016 Feb;54(2):478-82. doi: 10.1128/JCM.02945-15. Epub 2015 Dec 9.

44.

Mycobacterium alsense sp. nov., a scotochromogenic slow grower isolated from clinical respiratory specimens.

Tortoli E, Richter E, Borroni E, Cabibbe AM, Capitolo E, Cittaro D, Engel R, Hendricks O, Hillemann D, Kristiansen JE, Mariottini A, Schubert S, Cirillo DM.

Int J Syst Evol Microbiol. 2016 Jan;66(1):450-6. doi: 10.1099/ijsem.0.000744. Epub 2015 Nov 5.

PMID:
26545358
45.

Mycobacterium sherrisii Pulmonary Disease, Burkina Faso.

Borroni E, Badoum G, Cirillo DM, Matteelli A, Moyenga I, Ouedraogo M, Roggi A, Saleri N, Tagliani E, Tortoli E.

Emerg Infect Dis. 2015 Nov;21(11):2093-4. doi: 10.3201/eid2111.141809. No abstract available.

46.

Pituitary Adenoma and the Chemokine Network: A Systemic View.

Grizzi F, Borroni EM, Vacchini A, Qehajaj D, Liguori M, Stifter S, Chiriva-Internati M, Di Ieva A.

Front Endocrinol (Lausanne). 2015 Sep 11;6:141. doi: 10.3389/fendo.2015.00141. eCollection 2015. Review. No abstract available.

47.

Mycobacterium angelicum sp. nov., a non-chromogenic, slow-growing species isolated from fish and related to Mycobacterium szulgai.

Pourahmad F, Pate M, Ocepek M, Borroni E, Cabibbe AM, Capitolo E, Cittaro D, Frizzera E, Jenčič V, Mariottini A, Marumo K, Vaggelli G, Cirillo DM, Tortoli E.

Int J Syst Evol Microbiol. 2015 Dec;65(12):4724-9. doi: 10.1099/ijsem.0.000642. Epub 2015 Sep 28.

PMID:
26420689
48.

Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism.

Goonawardena AV, Heiss J, Glavis-Bloom C, Trube G, Borroni E, Alberati D, Wallace TL.

Neuropsychopharmacology. 2016 Apr;41(5):1319-28. doi: 10.1038/npp.2015.281. Epub 2015 Sep 10.

49.

Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.

Assmus F, Seelig A, Gobbi L, Borroni E, Glaentzlin P, Fischer H.

Eur J Pharm Sci. 2015 Nov 15;79:27-35. doi: 10.1016/j.ejps.2015.08.014. Epub 2015 Sep 2.

PMID:
26341407
50.

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.

Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM.

J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15.

Supplemental Content

Loading ...
Support Center